购物车

全部删除
您的购物车当前为空

前往下单页继续购物

IL-6 Protein, Human, Recombinant V2

一键复制产品信息

产品编号 TMPY-00863U

IL-6 Protein, Human, Recombinant V2 is expressed in E. coli. The accession number is P05231.

IL-6 Protein, Human, Recombinant V2

一键复制产品信息

产品编号 TMPY-00863U

IL-6 Protein, Human, Recombinant V2 is expressed in E. coli. The accession number is P05231.

规格	价格	库存	数量

大包装 & 定制

TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。

实验操作小课堂

常见问题解答

资源下载

重组蛋白用户指南

产品信息

生物活性	1. Immobilized Human IL-6 at 0.5 μg/ml (100 μl/Well) on the plate. Dose response curve for Human IL-6 R alpha, hFc Tag with the EC50 48.7 ng/ml determined by ELISA. 2. Human IL-6 R alpha, His Tag captured on CM5 Chip via anti-his antibody can bind Human IL-6, No Tag with an affinity constant of 0.22 nM as determined in SPR assay (Biacore T200). 3. Measured in a cell proliferation assay using TF‑1 human erythroleukemic cells. The ED50 for this effect is 0.1-0.5 ng/mL (QC Test).
产品描述	IL-6 Protein, Human, Recombinant V2 is expressed in E. coli. The accession number is P05231.
种属	Human
表达系统	E. coli
标签	Tag Free
蛋白编号	P05231
别名	白介素,Interleukin-6,interleukin 6,IL-6,IFNB2,HSF,HGF,BSF2
蛋白构建	Val30-Met212
蛋白纯度	> 95% as determined by Tris-Bis PAGE; > 90% as determined by HPLC
分子量	20.8 kDa (Predicted and reducing conditions)
内毒素	< 1.0 EU/μg of the protein as determined by the LAL method.
蛋白性状	Lyophilized powder
缓冲液	Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
存储	Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.
运输方式	In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice.
研究背景	IL-6 (Interleukin-6) is a pleiotropic cytokine that acts in the acute phase reaction, inflammation, hematopoiesis, bone metabolism, and cancer progression.Interleukin 6 has been shown to interact with interleukin-6 receptor and glycoprotein.